花粉症市場報告：到 2030 年的趨勢、預測和競爭分析

花粉症趨勢和預測

預計到 2030 年，全球花粉症市場將達到 72 億美元，2024 年至 2030 年複合年成長率為 4.5%。該市場的主要驅動力是過敏發生率的增加、過敏及其管理意識的提高以及持續的技術進步。全球花粉症市場的未來看起來充滿希望，食品、吸入和藥品市場充滿機會。

• Lucintel 預測，由於皮質類固醇的功效、安全性和可用性，在預測期內將繼續成為最大的領域。
• 在這個市場中，由於呼吸道過敏的高成長，吸入器仍將是最大的細分市場。
• 由於花粉症的高發生率和醫療基礎設施未得到滿足，預計亞太地區在預測期內將出現最高的成長。

花粉症市場的新趨勢

花粉症市場觀察到的一些主要趨勢是由人口變化和技術進步（包括環境意識）所驅動的。

• 個人化過敏治療：在過敏性疾病的治療中，人們越來越注重根據每個人的基因體質和自然環境的特徵進行個別化治療。這改善了治療結果和患者的生活品質。
• 數位健康整合：數位健康工具（包括行動應用程式和穿戴式裝置）的興起正在加強花粉症管理。這些技術有助於症狀追蹤、藥物管理、即時花粉預測等。
• 擴大生技藥品的使用：這類作用於過敏反應特定途徑的藥物的使用越來越多。這使得在治療嚴重過敏患者時可以採取更好的選擇性方法。
• 對環境影響的認知：提高對當前環境變化及其對花粉暴露程度影響的認知，有助於採取減少暴露程度和控制過敏反應症狀的策略。
• 擴大免疫治療選擇：除了舌下免疫療法和過敏原免疫療法外，現在還有更多可供過敏患者使用的免疫療法選擇，提供了更可行的長期治療選擇。

這些變化正在透過更個人化、有效且易於使用的治療方案重新調整花粉症市場。人們對改善患者治療結果的管理策略的認知也不斷提高和改進。

花粉症市場的最新趨勢

花粉症市場的最新趨勢是由有效治療、個人化治療、更好的診斷工具、改善的患者照護以及公眾對解決全球花粉症日益流行的認知的提高所推動的，這反映了花粉症日益成長的趨勢。

• 免疫療法的進展：舌下免疫療法和過敏原特異性免疫療法的改進正在提供更好的長期治療選擇。這些創新提高了依從性並減少了過敏症狀。
• 數位健康工具的普及：新的行動應用程式和穿戴式裝置使得追蹤花粉水平和管理症狀成為可能。這些數位工具具有最新資料和個人化提案。
• 生技藥品開發：針對過敏反應特定途徑的新生技藥品治療為嚴重過敏患者提供了先進的選擇。這些治療方法正在演變成更好的治療方法。
• 加強對環境因素的研究：氣候變遷和環境污染對花粉水平影響的研究正在帶來更好的過敏管理方法。它也對公共衛生政策和治療方法影響。
• 過敏測試的增加：先進的過敏診斷和測試的可用性正在透過早期檢測和個人化治療計劃、更好的過敏管理和減少過敏患者的痛苦來推動進步。

這些只是花粉症市場的變化，治療方案的品質和有效性的整體提高補充了對個人化和有效的過敏管理日益成長的需求。

花粉症市場的策略性成長機會

從策略角度來看，花粉症市場提供了充足的成長機會。這種成長機會體現在以下領域：其中包括：應用主導、技術開拓、疾病意識的提高以及整體過敏性疾病管理解決方案的相關需求和要求。

• 免疫治療服務的擴展：免疫治療服務的開發和擴展，包括舌下服務和過敏原特異性治療，增加了顯著成長的潛力。先進的治療方法因其長期有效性和其他相關益處而越來越受到患者的青睞，包括：
• 整合數位健康解決方案：投資數位健康解決方案，例如行動應用程式、監測過敏原暴露的微創穿戴裝置以及遠端監測患者身體參數，可以提高患者對健康和花粉症管理的參與度和即時資料。加強個人治療計劃的潛力。
• 生物療法的成長：治療嚴重過敏的生技藥品的開發和商業化的成長代表著一個重大機會。這些治療方法具有針對性，並且由於其有效性而越來越受到追捧。
• 宣傳宣傳活動：進行有關花粉症和可用治療方法的宣傳教育宣傳活動將創造需求，從而推動公司的市場發展。提高公眾意識將提高過敏管理解決方案的採用率。
• 滲透到新興市場：印度和中國等新興市場的過敏盛行率大幅上升，並具有巨大的成長潛力。透過圍繞新興市場的需求打造您的產品和服務，您可以接觸到龐大且不斷成長的基本客群。

花粉症市場的策略性成長機會帶來了技術創新、治療方法的擴大和患者照護的改善。能夠利用這些機會的公司將能夠在這個不斷轉型的市場中成功駕馭。

花粉症市場推廣因素/問題

花粉症市場是由技術開拓、經濟因素、監管問題以及挑戰所驅動的。正確理解這些因素將有助於有效地駕馭市場。

推動花粉症市場的因素如下：

1.技術發展：技術發展：生技藥品和數位健康解決方案等新的診斷和治療方法正在推動市場成長。這將建立更好的方法和治療方法來應對花粉症。

2.過敏發生率增加：全球花粉症的增加預計將增加對更好的治療和管理的需求，從而擴大市場規模並增加對過敏研究的投資。

3.政府措施：透過政府特定補貼和公共衛生宣傳活動對過敏領域的研究支持將有助於建立市場成長。改善過敏管理和治療解決方案的政策影響市場動態。

4. 提高公眾意識：提高對花粉症及其各種治療方法的認知有助於接受過敏管理解決方案。公共教育可以提高公眾意識。

5.透過擴大醫療保健的覆蓋範圍來滲透市場：根據健康需求，擴大醫療保健服務以及過敏治療和管理的覆蓋範圍是市場的強大促進因素，尤其是在快速成長的新興市場。因此，有效的過敏管理解決方案正在變得可用。

花粉症市場面臨的挑戰如下。

1.治療費用高昂：生技藥品和免疫療法等高度發達的過敏治療方法的費用對一些患者來說是難以承受的。這對市場成長和滲透提出了挑戰，特別是在低收入地區。

2. 監管障礙：新藥和新技術面臨嚴格的監管要求，延遲了市場進入並增加了開發成本。遵守這些法規是過敏市場營運公司面臨的主要挑戰之一。

3. 過敏反應的多樣性：個別過敏反應的複雜性使得尋找通用方法變得困難。在這方面，變異性會影響治療方法的有效性並影響市場的成長。

這些促進因素和挑戰是改變花粉症市場的相關力量，不僅影響新療法的開拓，也影響市場動態和患者獲得治療的機會。解決這些因素將是企業在不斷變化的市場環境中脫穎而出的關鍵因素。

花粉症依細分類別

本研究按治療層級、產品類型、過敏原類型、最終用途和地區對全球花粉症進行預測。

各國花粉症市場前景

由於治療方法的進步、環境條件的變化以及對過敏反應的意識提高，花粉症市場正在迅速發展。這些趨勢反映了每個地區個人化和有效管理花粉症的更廣泛趨勢。

• 美國：近年來，美國增加了針對過敏的新治療方法，例如 SLIT 和新生技藥品，以幫助控制花粉症。公眾意識的提高和新的數位健康工具也有助於控制過敏。
• 中國：先進的過敏測試和免疫治療方案正在中國取得進展。盛行率的不斷上升、政府對過敏研究和治療的興趣以及氣候變遷導致都市區花粉排放量的增加正在推動該國市場的成長。
• 德國：透過個人化免疫療法和改進的診斷工具，我們無疑處於推進過敏管理中精準醫學的開發和應用的前沿。我們也認真對待環境政策，以減少花粉暴露並改善過敏管理。
• 印度：過敏治療的意識正在增強。花粉症的蔓延和負擔得起的治療方法的可用性是市場成長的原因。該國也致力於提高公眾的診斷能力和健康教育。
• 日本：日本市場越來越關注更複雜的過敏原特異性免疫療法和滴鼻劑。最近，還整合了數位健康技術來幫助追蹤和管理症狀。隨著研究和開發的進展，針對花粉症的治療方法可能會出現。

常問問題

Q1.市場規模有多大？

答：到 2030 年，全球花粉症市場預計將達到 72 億美元。

Q2.市場成長預測如何？

答：2024年至2030年，全球花粉症市場預計將以4.5%的複合年成長率成長。

Q3.影響市場成長的關鍵促進因素有哪些？

答：這個市場的主要驅動力是過敏發生率的增加、過敏及其管理意識的提高以及持續的技術進步。

Q4.市場的主要細分市場是什麼？

答：花粉症市場的未來充滿希望，食品、吸入和藥品市場都有機會。

Q5.市場上主要企業有哪些？

答：花粉症相關企業如下。

• ALK-Abello
• Circassia
• DBV Technologies
• Genentech
• GlaxoSmithKline
• HAL Allergy
• Johnson & Johnson
• Meda AB
• Merck & Co
• Mylan

Q6.未來最大的細分市場是什麼？

答：Lucintel 預測，由於皮質類固醇的功效、安全性和可用性，在預測期內將繼續成為最大的領域。

Q7. 未來五年預計哪個地區的市場最大？

答：由於花粉症的高發生率和醫療基礎設施不發達，亞太地區預計在預測期內將出現最高的成長。

Q8. 可以客製化報告嗎？

答：是的，Lucintel 列出了 10% 的客製化服務，無需額外費用。

目錄

第1章執行摘要

第2章全球花粉症市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

• 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
• 全球花粉症市場趨勢（2018-2023）與預測（2024-2030）
• 按治療層級的全球花粉症市場
  • 抗組織胺藥
  • 減充血劑
  • 皮質類固醇
  • 肥大細胞穩定劑
  • 白三烯抑制劑
  • 鼻用抗膽鹼能藥物
  • 免疫調節劑
  • 自動注射腎上腺素
  • 免疫療法
• 按產品類型分類的全球花粉症市場
  • 裝置
  • 消耗品
  • 服務
• 按過敏原類型分類的全球花粉症市場
  • 食品
  • 吸入
  • 藥品
  • 其他
• 按最終用途分類的全球花粉症市場
  • 診斷實驗室
  • 醫院
  • 其他

第4章 2018-2030年區域市場趨勢及預測分析

• 按地區分類的全球花粉症市場
• 北美花粉症市場
• 歐洲花粉症市場
• 亞太花粉症市場
• 其他區域花粉症市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 按治療層級的全球花粉症市場成長機會
  • 按產品類型分類的全球花粉症市場成長機會
  • 按過敏原類型分類的全球花粉症市場成長機會
  • 全球花粉症市場成長機會（依最終用途）
  • 按地區分類的全球花粉症市場成長機會
• 全球花粉症市場新趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球花粉症市場的產能
  • 全球花粉症市場的合併、收購和合資企業
  • 認證和許可

第7章主要企業概況

• ALK-Abello
• Circassia
• DBV Technologies
• Genentech
• GlaxoSmithKline
• HAL Allergy
• Johnson & Johnson
• Meda AB
• Merck & Co
• Mylan

Pollen Allergy Trends and Forecast

The future of the global pollen allergy market looks promising with opportunities in the food, inhaled, and drug markets. The global pollen allergy market is expected to reach an estimated $7.2 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are growing occurrence of allergies, rising awareness towards allergies and their management, and on-going technological advancements.

• Lucintel forecasts that corticosteroids will remain the largest region over the forecast period due to its effectiveness, safety, and availability.
• Within this market, inhaled will remain the largest segment due to high growth of respiratory allergies.
• APAC is expected to witness highest growth over the forecast period due to high prevalence of pollen allergies and presence of unmet healthcare infrastructure in the region.

Emerging Trends in the Pollen Allergy Market

A few of the important trends observed in the pollen allergy market are driven by changes in demography and technological advancement-including environmental awareness.

• Personalized Allergy Treatments: Increasingly, there is focus on personalized medicine in the treatment of allergic conditions based on the specific characteristics of each individual's genetic makeup and natural environmental exposure. This is improving treatment outcomes and the quality of patients' lives.
• Digital Health Integration: The rise of digital health tools, including mobile apps and wearable devices, is enhancing pollen allergy management. These technologies help track symptoms, manage medications, and provide real-time pollen forecasts.
• Greater Use of Biologics: There is greater use of drugs in this class, as they act on specific pathways in the allergic response. This allows for better and more selective approaches to the treatment of individuals with severe allergies.
• Awareness of the Impact of the Environment: There is increased awareness regarding the current changes in the environment and their consequences for the levels of exposure to pollen, encouraging strategies for reducing the level of exposure and managing the symptoms of allergic reactions.
• Expanding the Basket of Immunotherapy Options: Besides sublingual and allergen immunotherapies, a widening array of immunotherapies is now available for allergy sufferers, affording more viable long-term treatment options and thus yielding better patient outcomes that give more momentum to the growth of the market.

These changes are reconditioning the pollen allergy market with more personalized, effective, and accessible treatment options. They are increasing awareness and improvements in management strategies to achieve better patient outcomes.

Recent Developments in the Pollen Allergy Market

The recent developments in pollen allergy markets reflect the growing trend toward effective treatment, treatment personalization, better diagnostic tools, and heightened mass awareness in order to improve patient care and tackle the growing prevalence of pollen allergy worldwide.

• Advancement in Immunotherapy: Improvement in sublingual and allergen-specific immunotherapies is offering superior long-term treatment options. These technological innovations are leading to increased compliance and reducing the intensity of allergy symptoms.
• Increased Adoption of Digital Health Tools: New mobile applications and wearable devices have allowed tracking of pollen levels along with the management of symptoms. These digital tools provide current data and personalized suggestions.
• Development of Biologic Drugs: New biologic treatments targeting specific pathways in allergic reactions are offering advanced options for patients with severe allergies. These drugs are leading to better and improved ways of treatment.
• Increased Research on Environmental Factors: Research on climate change and environmental pollution effects on pollen amounts is leading to better allergy management approaches. It is also influencing public health policies and modes of treatment.
• Increased Allergy Testing: Advanced diagnostics and availability of testing for allergies spur development through early detection and personalized treatment plans, better allergy management, and alleviating the sufferings of allergic people.

These are indeed changes in the face of the pollen allergy market, where overall improvement in the quality and effectiveness of the treatment options compensates for the growing need for personalized and effective allergy management.

Strategic Growth Opportunities for Pollen Allergy Market

The market for pollen allergies has provided ample opportunities for growth from a strategic standpoint, as this can be reflected in the following areas: application-driven, technological developments, an increase in awareness toward the disease, and associated needs or demand for overall management solutions of the allergic condition.

• Expanding Immunotherapy Services: Developing and expanding immunotherapy services, including sublingual services and allergen-specific therapies, increases significant growth potential. Advanced treatments, which are being increasingly patronized by patients due to their long-term effectiveness and other associated benefits, include:.
• Digital Health Solution Integration: Investment in digital health solutions, such as mobile apps, wearable devices that are minimally invasive for monitoring allergen exposure, and remote monitoring of the patients' body parameters-huge potential to enhance engagement of patients in their health and pollen allergy management, in real-time data, and treatment planning on a personal basis.
• Growth in Biologic Treatments: Growth in the development and commercialization of biologic drugs for severe allergies is at a critical opportunity. These treatments are targeted and are sought after increasingly due to their efficiency.
• Awareness Campaigns: By launching the sensitization educational campaigns on pollen allergy and treatments available, demand will be created and thereby drive the market for the company. Increased public awareness will result in the adoption of high rates of solutions for the management of allergies.
• Emerging Market Penetration: Emerging markets like India and China, depicting a high rise in prevalence due to allergies, will provide a huge growth potential. Molding products and services in line with the requirements of the emerging markets will capture a large and growing customer base.

The strategic opportunities for growth in the pollen allergy market brought innovation, expansion to the treatments, and improved patient care. Companies able to capitalize on opportunities are well diluted to navigate the market as it continues to transform.

Pollen Allergy Market Driver and Challenges

The pollen allergy market is driven as well as challenged by technological developments, economic factors, and regulatory concerns. Proper insight into the factors will help one wade through the market effectively.

The factors responsible for driving the pollen allergy market include:

1. Technological Developments: New diagnosis and treatment methods such as biologics and digital health solutions are driving growth in the market. This sets a better approach to dealing with pollen allergies and treated ways.

2. Increased Incidence of Allergies: Due to global increase in pollen allergies, the demand for better treatment and management is likely to rise, which in turn shall increase the market size and investment in allergy research.

3. Government Initiatives: Support for research in the domain of allergies through subsidies by the government and public health campaigns help to establish market growth. The policies to improve allergy management and solutions in treatment influence market dynamics.

4. Increasing Public Awareness: Increasing awareness on pollen allergy and its various methods of treatment is aiding in the acceptance of solutions for the management of allergies. Public education has made increasing public awareness possible.

5. Market Penetration due to Expansion of Healthcare Access: In line with the health needs, access and expansion into healthcare services and treatment or management of allergies, particularly in the fast-growing or emerging markets, are poised as strong drivers of the market. This, in turn, is making available efficient solutions for allergy management.

Challenges in the pollen allergy market are:

1. High Treatment Costs: The cost of highly developed allergy treatment, like biologics and immunotherapy, is unaffordable to some patients. This acts as a challenge to the growth and adoption in the market, especially in lower-income regions.

2. Regulatory Hurdles: New drugs and technology face strict regulatory requirements, which delay entry into the market and translate into growing development costs. Following such regulations is one of the key challenges the companies working in the allergy market face.

3. Variability of Allergic Reactions: It is the sophistication of the individual allergic reaction that has made the search for a common approach difficult. In this regard, variability influences how treatments can be effective; thus, it affects the growth of the market.

These drivers and challenges are pertinent forces changing the pollen allergy market, which not only determines new treatment developments but also the market dynamics and accessibility of care to patients. Working on these elements will be a key factor in the emergence of enterprises in the changing market scenario.

List of Pollen Allergy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies pollen allergy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pollen allergy companies profiled in this report include-

• ALK-Abello
• Circassia
• DBV Technologies
• Genentech
• GlaxoSmithKline
• HAL Allergy
• Johnson & Johnson
• Meda AB
• Merck & Co
• Mylan

Pollen Allergy by Segment

The study includes a forecast for the global pollen allergy by therapeutics drug class, product type, allergen type, end use, and region.

Pollen Allergy Market by Therapeutics Drug Class [Analysis by Value from 2018 to 2030]:

• Antihistamines
• Decongestants
• Corticosteroids
• Mast Cell Stabilizers
• Leukotriene Inhibitors
• Nasal Anticholinergics
• Immunomodulators
• Auto injectable Epinephrine
• Immunotherapy

Pollen Allergy Market by Product Type [Analysis by Value from 2018 to 2030]:

• Instruments
• Consumables
• Services

Pollen Allergy Market by Allergen Type [Analysis by Value from 2018 to 2030]:

• Food
• Inhaled
• Drug
• Others

Pollen Allergy Market by End Use [Analysis by Value from 2018 to 2030]:

• Diagnostic Laboratories
• Hospitals
• Others

Pollen Allergy Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Pollen Allergy Market

The pollen allergy market is evolving rapidly due to advancements in treatments, changing environmental conditions, and increased awareness of allergic reactions. These developments reflect a broader trend toward personalized and effective management of pollen allergies across different regions.

• United States: Over the past few years, new treatments for allergies, such as SLIT and new biologic medications, have grown in the U.S., which has helped the management of pollen allergy. More awareness among the general public and new digital health tools also help in the management of the allergy.
• China: In China, there is growing infiltration by advanced allergy testing and immunotherapy options. Increasing prevalence, government interest in allergy research and treatment, along with high pollen counts in urban areas because of climate change, is driving market growth in the country.
• Germany is no doubt at the front line in advancing the development and application of precision medicine in managing allergies through personalized immunotherapy and improved diagnostic tools. It also dedicates some seriousness to the environmental policies it creates with a view to reduced pollen exposure and improving allergy management at large.
• India: With availability, the awareness about allergy treatments is increasing. Greater pollen allergies and availability of treatments at reasonable prices are the reasons for the market's growth. Besides, the country is putting emphasis on diagnostic capability building and health education of the general public.
• Japan: Japanese markets are increasingly focusing on more sophisticated allergen-specific immunotherapy and nasal sprays. In recent times, they have also integrated digital health technologies that help track symptoms and manage them. With increased research and development, the treatments are going to be more specific in the case of pollen allergies.

Features of the Global Pollen Allergy Market

Market Size Estimates: Pollen allergy market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pollen allergy market size by various segments, such as by therapeutics drug class, product type, allergen type, end use, and region in terms of value ($B).

Regional Analysis: Pollen allergy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapeutics drug classes, product types, allergen types, end uses, and regions for the pollen allergy market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pollen allergy market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the pollen allergy market size?

Answer: The global pollen allergy market is expected to reach an estimated $7.2 billion by 2030.

Q2. What is the growth forecast for pollen allergy market?

Answer: The global pollen allergy market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the pollen allergy market?

Answer: The major drivers for this market are growing occurrence of allergies, rising awareness towards allergies and their management, and on-going technological advancements.

Q4. What are the major segments for pollen allergy market?

Answer: The future of the pollen allergy market looks promising with opportunities in the food, inhaled, and drug markets.

Q5. Who are the key pollen allergy market companies?

Answer: Some of the key pollen allergy companies are as follows:

• ALK-Abello
• Circassia
• DBV Technologies
• Genentech
• GlaxoSmithKline
• HAL Allergy
• Johnson & Johnson
• Meda AB
• Merck & Co
• Mylan

Q6. Which pollen allergy market segment will be the largest in future?

Answer: Lucintel forecasts that corticosteroids will remain the largest region over the forecast period due to its effectiveness, safety, and availability.

Q7. In pollen allergy market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to high prevalence of pollen allergies and presence of unmet healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the pollen allergy market by therapeutics drug class (antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, immunomodulators, auto injectable epinephrine, and immunotherapy), product type (instruments, consumables, and services), allergen type (food, inhaled, drug, and others), end use (diagnostic laboratories, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Pollen Allergy Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Pollen Allergy Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Pollen Allergy Market by Therapeutics Drug Class
  • 3.3.1: Antihistamines
  • 3.3.2: Decongestants
  • 3.3.3: Corticosteroids
  • 3.3.4: Mast Cell Stabilizers
  • 3.3.5: Leukotriene Inhibitors
  • 3.3.6: Nasal Anticholinergics
  • 3.3.7: Immunomodulators
  • 3.3.8: Auto injectable Epinephrine
  • 3.3.9: Immunotherapy
• 3.4: Global Pollen Allergy Market by Product Type
  • 3.4.1: Instruments
  • 3.4.2: Consumables
  • 3.4.3: Services
• 3.5: Global Pollen Allergy Market by Allergen Type
  • 3.5.1: Food
  • 3.5.2: Inhaled
  • 3.5.3: Drug
  • 3.5.4: Others
• 3.6: Global Pollen Allergy Market by End Use
  • 3.6.1: Diagnostic Laboratories
  • 3.6.2: Hospitals
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Pollen Allergy Market by Region
• 4.2: North American Pollen Allergy Market
  • 4.2.1: North American Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
  • 4.2.2: North American Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
• 4.3: European Pollen Allergy Market
  • 4.3.1: European Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
  • 4.3.2: European Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
• 4.4: APAC Pollen Allergy Market
  • 4.4.1: APAC Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
  • 4.4.2: APAC Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
• 4.5: ROW Pollen Allergy Market
  • 4.5.1: ROW Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
  • 4.5.2: ROW Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Pollen Allergy Market by Therapeutics Drug Class
  • 6.1.2: Growth Opportunities for the Global Pollen Allergy Market by Product Type
  • 6.1.3: Growth Opportunities for the Global Pollen Allergy Market by Allergen Type
  • 6.1.4: Growth Opportunities for the Global Pollen Allergy Market by End Use
  • 6.1.5: Growth Opportunities for the Global Pollen Allergy Market by Region
• 6.2: Emerging Trends in the Global Pollen Allergy Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Pollen Allergy Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pollen Allergy Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: ALK-Abello
• 7.2: Circassia
• 7.3: DBV Technologies
• 7.4: Genentech
• 7.5: GlaxoSmithKline
• 7.6: HAL Allergy
• 7.7: Johnson & Johnson
• 7.8: Meda AB
• 7.9: Merck & Co
• 7.10: Mylan